Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adultsGut, 2015-11, Vol.64 (11), p.1744-1754 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Copyright: 2015 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2015 ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2014-307913 ;PMID: 25500202 ;CODEN: GUTTAKFull text available |
|
2 |
Material Type: Article
|
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trialNature medicine, 2022-10, Vol.28 (10), p.2083-2091 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-022-02026-4 ;PMID: 36216945Full text available |
|
3 |
Material Type: Article
|
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trialsThe Lancet (British edition), 2022-01, Vol.399 (10321), p.259-269 [Peer Reviewed Journal]Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01640-8 ;PMID: 34895470Full text available |
|
4 |
Material Type: Article
|
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b StudyDiabetes care, 2021-06, Vol.44 (6), p.1433-1442 [Peer Reviewed Journal]2021 by the American Diabetes Association. ;Copyright American Diabetes Association Jun 1, 2021 ;2021 by the American Diabetes Association 2021 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-2151 ;PMID: 34016612Full text available |
|
5 |
Material Type: Article
|
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and designThe American heart journal, 2020-11, Vol.229, p.61-69 [Peer Reviewed Journal]2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. The Author(s) ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2020.07.008 ;PMID: 32916609Full text available |
|
6 |
Material Type: Article
|
Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsThe New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1808721 ;PMID: 30145941Full text available |
|
7 |
Material Type: Article
|
Natural Dietary and Herbal Products in Anti-Obesity TreatmentMolecules, 2016-10, Vol.21 (10), p.1351 [Peer Reviewed Journal]Copyright MDPI AG 2016 ;2016 by the authors. 2016 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules21101351 ;PMID: 27727194Full text available |
|
8 |
Material Type: Article
|
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer FormulationDiabetes (New York, N.Y.), 2016-08, Vol.65 (8), p.2282-2294 [Peer Reviewed Journal]2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Aug 1, 2016 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db16-0153 ;PMID: 27207552 ;CODEN: DIAEAZFull text available |
|
9 |
Material Type: Article
|
Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practicePostgraduate medicine, 2022, Vol.134 (1), p.14-19 [Peer Reviewed Journal]2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;ISSN: 0032-5481 ;EISSN: 1941-9260 ;DOI: 10.1080/00325481.2021.2002616Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humansThe American journal of clinical nutrition, 2020-08, Vol.112 (2), p.413-426 [Peer Reviewed Journal]2020 American Society for Nutrition. ;Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. 2020 ;Copyright © The Author(s) on behalf of the American Society for Nutrition 2020. ;Copyright American Society for Clinical Nutrition, Inc. Aug 2020 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.1093/ajcn/nqaa072 ;PMID: 32320006Full text available |
|
11 |
Material Type: Article
|
Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover studyDiabetologia, 2019-04, Vol.62 (4), p.665-675 [Peer Reviewed Journal]Springer-Verlag GmbH Germany, part of Springer Nature 2019 ;Diabetologia is a copyright of Springer, (2019). All Rights Reserved. ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-018-4810-0 ;PMID: 30683945Full text available |
|
12 |
Material Type: Article
|
Short-chain fatty acids as anti-inflammatory agents in overweight and obesity: a systematic review and meta-analysisNutrition reviews, 2022-03, Vol.80 (4), p.838-856 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0029-6643 ;EISSN: 1753-4887 ;DOI: 10.1093/nutrit/nuab059 ;PMID: 34472619Full text available |
|
13 |
Material Type: Article
|
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight ManagementThe New England journal of medicine, 2010-07, Vol.363 (3), p.245-256 [Peer Reviewed Journal]Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2010 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0909809 ;PMID: 20647200 ;CODEN: NEJMAGFull text available |
|
14 |
Material Type: Article
|
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristicsObesity (Silver Spring, Md.), 2023-01, Vol.31 (1), p.111-122 [Peer Reviewed Journal]2022 The Authors. published by Wiley Periodicals LLC on behalf of The Obesity Society. ;2022 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society. ;Copyright Blackwell Publishing Ltd. Jan 2023 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.23621 ;PMID: 36502289Full text available |
|
15 |
Material Type: Article
|
Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary SyndromeThe journal of clinical endocrinology and metabolism, 2015-11, Vol.100 (11), p.4048-4058 [Peer Reviewed Journal]Copyright © 2015 by the Endocrine Society ;Copyright © 2015 by The Endocrine Society ;Copyright © 2015 by the Endocrine Society 2015 ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2015-2778 ;PMID: 26401593Full text available |
|
16 |
Material Type: Article
|
Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled TrialDiabetes care, 2020-05, Vol.43 (5), p.1085-1093 [Peer Reviewed Journal]2020 by the American Diabetes Association. ;Copyright American Diabetes Association May 1, 2020 ;2020 by the American Diabetes Association 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc19-1745 ;PMID: 32139381Full text available |
|
17 |
Material Type: Article
|
Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP ProgramDiabetes care, 2022-10, Vol.45 (10), p.2396-2405 [Peer Reviewed Journal]2022 by the American Diabetes Association. ;Copyright American Diabetes Association Oct 2022 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc21-1785 ;PMID: 35724304Full text available |
|
18 |
Material Type: Article
|
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension studyThe American journal of clinical nutrition, 2012-02, Vol.95 (2), p.297-308 [Peer Reviewed Journal]2012 American Society for Nutrition. ;2015 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. Feb 1, 2012 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.3945/ajcn.111.024927 ;PMID: 22158731 ;CODEN: AJCNACFull text available |
|
19 |
Material Type: Article
|
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 DiabetesDiabetes care, 2013-12, Vol.36 (12), p.4022-4029 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2013 American Diabetes Association ;Copyright American Diabetes Association Dec 2013 ;2013 by the American Diabetes Association. 2013 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-0234 ;PMID: 24144653 ;CODEN: DICAD2Full text available |
|
20 |
Material Type: Article
|
Benefits of weight loss of 10% or more in patients with overweight or obesity: A reviewObesity (Silver Spring, Md.), 2022-04, Vol.30 (4), p.802-840 [Peer Reviewed Journal]2022 The Obesity Society ;2022 The Obesity Society. ;Copyright Blackwell Publishing Ltd. Apr 2022 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1002/oby.23371 ;PMID: 35333446Full text available |